Your browser doesn't support javascript.
loading
EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer.
Hung, Anna; Lee, Kyung Min; Alba, Patrick R; Li, Yanhong; Gao, Anthony Z; Hintze, Bradley J; Efimova, Olga V; Shenolikar, Rahul; Pavilack, Melissa; Simmons, Dan; Kelley, Michael J; Lynch, Julie A; Reed, Shelby D.
Afiliación
  • Hung A; Duke Clinical Research Institute, Duke University School of Medicine, Durham, VA, United States; Department of Population Health Sciences, Duke University School of Medicine, Durham, VA, United States; Department of Veteran Affairs Medical Center, Durham, NC, United States. Electronic address: anna.
  • Lee KM; Department of Veteran Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States.
  • Alba PR; Department of Veteran Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States.
  • Li Y; Duke Clinical Research Institute, Duke University School of Medicine, Durham, VA, United States; Department of Veteran Affairs Medical Center, Durham, NC, United States.
  • Gao AZ; Department of Veteran Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States.
  • Hintze BJ; Duke Clinical Research Institute, Duke University School of Medicine, Durham, VA, United States; Department of Veteran Affairs Medical Center, Durham, NC, United States.
  • Efimova OV; Department of Veteran Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States.
  • Shenolikar R; AstraZeneca, Gaithersburg, MD, United States.
  • Pavilack M; AstraZeneca, Gaithersburg, MD, United States.
  • Simmons D; AstraZeneca, Gaithersburg, MD, United States.
  • Kelley MJ; Department of Veteran Affairs Medical Center, Durham, NC, United States; Duke University Medical Center, Durham, NC, United States.
  • Lynch JA; Department of Veteran Affairs Salt Lake City Health Care System, Salt Lake City, UT, United States.
  • Reed SD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, VA, United States; Department of Population Health Sciences, Duke University School of Medicine, Durham, VA, United States; Department of Veteran Affairs Medical Center, Durham, NC, United States.
Cancer Treat Res Commun ; 27: 100327, 2021.
Article en En | MEDLINE | ID: mdl-33549984
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Pautas de la Práctica en Medicina / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Treat Res Commun Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Pautas de la Práctica en Medicina / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Proteínas Quinasas / Neoplasias Pulmonares Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Cancer Treat Res Commun Año: 2021 Tipo del documento: Article